These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19892591)
1. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab. Uppal R; Charles E; Lake-Bakaar G J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358 [TBL] [Abstract][Full Text] [Related]
3. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C? Ahmed MS; Wong CF J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269 [TBL] [Abstract][Full Text] [Related]
4. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. Cai FZ; Ahern M; Smith M J Rheumatol; 2006 Jun; 33(6):1197-8. PubMed ID: 16755669 [TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment. Roll P; Dörner T; Tony HP Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772 [TBL] [Abstract][Full Text] [Related]
6. Increased T-cell sinusoidal lymphocytosis in liver biopsies in patients with chronic hepatitis C and mixed cryoglobulinemia. Carmack S; Taddei T; Robert ME; Mistry P; Jain D Am J Gastroenterol; 2008 Mar; 103(3):705-11. PubMed ID: 17970837 [TBL] [Abstract][Full Text] [Related]
7. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders. Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450 [TBL] [Abstract][Full Text] [Related]
8. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292 [TBL] [Abstract][Full Text] [Related]
9. [An autopsy case of systemic vasculitis associated with hepatitis C virus-related mixed cryoglobulinemia presenting severe peripheral neuropathy]. Tada M; Naruse S; Arai A; Sato A; Tanaka K; Piao YS; Kakita A; Takahashi H; Nishizawa M; Tsuji S Rinsho Shinkeigaku; 2004 Oct; 44(10):686-90. PubMed ID: 15568485 [TBL] [Abstract][Full Text] [Related]
10. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235 [TBL] [Abstract][Full Text] [Related]
11. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders. Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535 [TBL] [Abstract][Full Text] [Related]
12. Clonal CD27+ CD19+ B cell expansion through inhibition of FC gammaIIR in HCV(+) cryoglobulinemic patients. De Re V; Pavan A; Sansonno S; Sansonno D; Racanelli V Ann N Y Acad Sci; 2009 Sep; 1173():326-33. PubMed ID: 19758169 [TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis]. Milovanova SIu; Lopatkina TN; Kozlovskaia LV; Krasnova TN Ter Arkh; 2007; 79(6):69-72. PubMed ID: 17684972 [No Abstract] [Full Text] [Related]
14. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712 [TBL] [Abstract][Full Text] [Related]
15. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594 [TBL] [Abstract][Full Text] [Related]
16. In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody. Sidner RA; Book BK; Agarwal A; Bearden CM; Vieira CA; Pescovitz MD Hum Antibodies; 2004; 13(3):55-62. PubMed ID: 15598985 [TBL] [Abstract][Full Text] [Related]
17. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196 [TBL] [Abstract][Full Text] [Related]
18. Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC. Cacoub P; Hausfater P; Musset L; Piette JC Ann Med Interne (Paris); 2000 Feb; 151(1):20-9. PubMed ID: 10761559 [TBL] [Abstract][Full Text] [Related]
19. [The extrahepatic site of hepatitis C virus: clinical manifestations and prognostic value]. Krel' PE; Tsinzerling OD Ter Arkh; 2009; 81(11):63-8. PubMed ID: 20141018 [TBL] [Abstract][Full Text] [Related]
20. B-cells and mixed cryoglobulinemia. Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]